Aleixandre A, López-Miranda V, Ortega A
Department of Pharmacology, Faculty of Medicine, Complutense University, Madrid, Spain.
J Cardiovasc Pharmacol. 2001 Feb;37(2):133-42. doi: 10.1097/00005344-200102000-00001.
Apart from the direct actions of nitric oxide (NO) on vascular smooth muscle, this factor may regulate cardiovascular functions through specific actions on alpha-adrenergic constrictor mechanisms. In this study we aim to establish whether the inhibition of the synthesis of this mediator could alter the vasoconstrictor responses mediated by alpha-adrenoceptor stimulation. We have been able to demonstrate that the blockage of the NO synthase really does exist, when both short- and long-term treatments with Nomega-nitro-Larginine methyl ester (L-NAME) are carried out. We have evaluated the concentration-dependent contractions induced by the selective alpha1-adrenoceptor agonists methoxamine and phenylephrine in isolated rat aorta rings in the following groups of animals: control, short-term L-NAME-treated (100 mg/kg i.p. 20 min before subjecting the animals to the experiments) and long-term L-NAME-treated (100 mg/kg per day in the drinking water for 7, 21, or 45 days). We have also evaluated the pressor responses to methoxamine and to the selective alpha-adrenoceptor agonist B-HT 920 using the pithed rat preparation in the same groups of animals. The contractile responses to methoxamine and phenylephrine were similar in the rat aorta preparations from control and short-term L-NAME-treated animals. On the contrary, in the rat aorta preparations from long-term L-NAME-treated animals these responses were clearly reduced when compared with the corresponding responses in those from control animals, the reduction being more marked when the treatment lasted longer. The pressor responses to methoxamine were also similar in control and short-term L-NAME-treated pithed rats. Nevertheless, the responses to B-HT 920 were greater in the latter. On the other hand, the dose-response curves to both alpha-adrenoceptor agonists were shifted to the right in a non-parallel manner in rats treated long term with L-NAME, the shift being, in the case of B-HT 920, more accentuated when the treatment lasted 21 or 45 days than when it lasted only 7 days. These results indicate that the short-term decrease in NO synthesis does not modify the vascular smooth muscle responses mediated by alpha1-adrenoceptor stimulation, but it does induce a potentiation of sympathetic vasoconstriction mediated by alpha2-adrenoceptors. Nevertheless, the long-term inhibition of NO synthesis causes a compensating decrease in the alpha1- and alpha2-vascular smooth muscle contractile responses.
除了一氧化氮(NO)对血管平滑肌的直接作用外,该因子还可能通过对α-肾上腺素能收缩机制的特定作用来调节心血管功能。在本研究中,我们旨在确定抑制这种介质的合成是否会改变由α-肾上腺素能受体刺激介导的血管收缩反应。当用Nω-硝基-L-精氨酸甲酯(L-NAME)进行短期和长期治疗时,我们已经能够证明一氧化氮合酶的阻断确实存在。我们评估了在以下几组动物的离体大鼠主动脉环中,选择性α1-肾上腺素能受体激动剂甲氧明和去氧肾上腺素诱导的浓度依赖性收缩:对照组、短期L-NAME治疗组(在对动物进行实验前20分钟腹腔注射100 mg/kg)和长期L-NAME治疗组(在饮用水中每天给予100 mg/kg,持续7、21或45天)。我们还使用相同组的动物制备的脊髓横断大鼠评估了对甲氧明和选择性α-肾上腺素能受体激动剂B-HT 920的升压反应。在对照组和短期L-NAME治疗的动物的大鼠主动脉制备物中,对甲氧明和去氧肾上腺素的收缩反应相似。相反,在长期L-NAME治疗的动物的大鼠主动脉制备物中,与对照组动物的相应反应相比,这些反应明显降低,治疗持续时间越长,降低越明显。在对照组和短期L-NAME治疗的脊髓横断大鼠中,对甲氧明的升压反应也相似。然而,后者对B-HT 920的反应更大。另一方面,在长期用L-NAME治疗的大鼠中,两种α-肾上腺素能受体激动剂的剂量-反应曲线以非平行方式向右移动,就B-HT 920而言,治疗持续21或45天时的移动比仅持续7天时更明显。这些结果表明,短期一氧化氮合成减少不会改变由α1-肾上腺素能受体刺激介导的血管平滑肌反应,但会诱导由α2-肾上腺素能受体介导的交感神经血管收缩增强。然而,长期抑制一氧化氮合成会导致α1-和α2-血管平滑肌收缩反应的代偿性降低。